SEC Filing Timeline
10-QAug 06, 2026
Quarterly report
8-KAug 06, 2026
Earnings release · Items 2.02,9.01
DEFA14AJul 30, 2026
Additional proxy
DEF 14AJul 30, 2026
Proxy statement
8-KJul 13, 2026
Other material event · Items 8.01,9.01
8-KJun 11, 2026
Other material event · Items 5.07,8.01
8-KJun 03, 2026
Executive officer change · Items 5.02
8-KMay 14, 2026
Executive officer change · Items 5.02,8.01
8-KMay 14, 2026
Unregistered share issuance · Items 2.03,3.02,7.01,9.01
10-QMay 08, 2026
Quarterly report
8-KMay 07, 2026
Unregistered share issuance · Items 1.01,1.02,2.02,2.03,3.02,9.01
8-KMay 05, 2026
Earnings release · Items 2.02,8.01,9.01
8-KMay 04, 2026
Earnings release · Items 2.02,7.01,8.01,9.01
DEFA14AApr 28, 2026
Additional proxy
DEF 14AApr 28, 2026
Proxy statement
Recent News (Finnhub)
Ocugen, Inc. (OCGN) Q2 2026 Earnings Call Transcript
Ocugen (NASDAQ:OCGN) Falls on Mixed Q2 Results as Revenue Beat Offsets Wider Loss
Ocugen Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $1.488M Beat $888.833K Estimate
FDA Grants RMAT Designation To Ocugen’s Investigational Product OCU410 For Treatment Of Geographic Atrophy, Secondary To Dry Ag…